US 11345678
Benzopyrazole compound used as RHO kinase inhibitor
granted A61PA61P11/00
Quick answer
US patent 11345678 (Benzopyrazole compound used as RHO kinase inhibitor) held by Medshine Discovery Inc. expires Mon May 26 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Medshine Discovery Inc.
- Grant date
- Tue May 31 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon May 26 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 19
- CPC classes
- A61P, A61P11/00